Therefore, like VEGF-C, ECM1 appears to be a potent enhancer of tumor lymphangiogenesis and may contribute to an increased rate of metastatic spread of breast cancer cells to the lymph nodes. This evidence concerns the gene ECM1 and breast cancer.